Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes.
Wolf, P
Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes. [electronic resource] - Nutrition, metabolism, and cardiovascular diseases : NMCD 05 2016 - 387-92 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1590-3729
10.1016/j.numecd.2016.03.012 doi
Adipose Tissue--drug effects
Aged
Austria
Biomarkers--blood
Diabetes Mellitus, Type 2--blood
Diabetic Cardiomyopathies--blood
Down-Regulation
Energy Metabolism--drug effects
Fatty Acids, Nonesterified--blood
Female
Humans
Hypolipidemic Agents--adverse effects
Lipolysis--drug effects
Magnetic Resonance Imaging
Male
Middle Aged
Myocardium--metabolism
Proton Magnetic Resonance Spectroscopy
Pyrazines--adverse effects
Risk Factors
Single-Blind Method
Stroke Volume--drug effects
Systole
Time Factors
Treatment Outcome
Ventricular Function, Left--drug effects
Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes. [electronic resource] - Nutrition, metabolism, and cardiovascular diseases : NMCD 05 2016 - 387-92 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1590-3729
10.1016/j.numecd.2016.03.012 doi
Adipose Tissue--drug effects
Aged
Austria
Biomarkers--blood
Diabetes Mellitus, Type 2--blood
Diabetic Cardiomyopathies--blood
Down-Regulation
Energy Metabolism--drug effects
Fatty Acids, Nonesterified--blood
Female
Humans
Hypolipidemic Agents--adverse effects
Lipolysis--drug effects
Magnetic Resonance Imaging
Male
Middle Aged
Myocardium--metabolism
Proton Magnetic Resonance Spectroscopy
Pyrazines--adverse effects
Risk Factors
Single-Blind Method
Stroke Volume--drug effects
Systole
Time Factors
Treatment Outcome
Ventricular Function, Left--drug effects